IG Review of FISA Compliance Completed But Not Released
The Office of the Inspector General (OIG) of the Department of Justice said it had recently completed a review of the Department’s use of Section 702 of the Foreign Intelligence Surveillance Act (FISA) Amendments Act (FAA), but the report is classified and its findings have not been released.
“The OIG examined the number of disseminated FBI intelligence reports containing a reference to a U.S. person identity, the number of U.S. person identities subsequently disseminated in response to requests for identities not referred to by name or title in the original reporting, the number of targets later determined to be located in the United States, and whether communications of such targets were reviewed. The OIG also reviewed the FBI’s compliance with the required targeting and minimization procedures,” according to a November 7 OIG memorandum on Top Management and Performance Challenges in the Department of Justice.
A copy of the classified report has been requested under the Freedom of Information Act.
Earlier this year, Sen. Ron Wyden placed a hold on reauthorization of the FISA Amendments Act “because I believe that Congress does not have enough information about this law’s impact on the privacy of law-abiding American citizens, and because I am concerned about a loophole in the law that could allow the government to effectively conduct warrantless searches for Americans’ communications.”
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.